[HTML][HTML] Maraviroc prevents HCC development by suppressing macrophages and the liver progenitor cell response in a murine chronic liver disease model
AM Passman, RP Strauss, SB McSpadden… - Cancers, 2021 - mdpi.com
Simple Summary Liver stem cells and activated macrophages have been implicated as
contributors to liver cancer; hence, reducing their abundance is a potential avenue for …
contributors to liver cancer; hence, reducing their abundance is a potential avenue for …
[HTML][HTML] Immune-stimulatory effects of curcumin on the tumor microenvironment in head and neck squamous cell carcinoma
Simple Summary Head and neck squamous cell carcinoma has been shown to
downregulate the host's antitumor immune response as well as inherent anticancer …
downregulate the host's antitumor immune response as well as inherent anticancer …
Radiation therapy and the innate immune response: Clinical implications for immunotherapy approaches
V Gómez, R Mustapha, K Ng… - British journal of clinical …, 2020 - Wiley Online Library
Radiation therapy is an essential component of cancer care, contributing up to 40% of
curative cancer treatment regimens. It creates DNA double‐strand breaks causing cell death …
curative cancer treatment regimens. It creates DNA double‐strand breaks causing cell death …
[HTML][HTML] The thyroid tumor microenvironment: potential targets for therapeutic intervention and prognostication
L MacDonald, J Jenkins, G Purvis, J Lee… - Hormones and Cancer, 2020 - Springer
Thyroid cancer is the most common endocrine malignancy and incidences are rising rapidly,
in both pediatric and adult populations. Many thyroid tumors are successfully treated which …
in both pediatric and adult populations. Many thyroid tumors are successfully treated which …
[HTML][HTML] Research progress on the role of tumor-associated macrophages in tumor development and their use as molecular targets
C Lu, Y Liu, L Miao, X Kong, H Li… - International …, 2023 - spandidos-publications.com
The tumor microenvironment (TME) is a complex system composed mainly of tumor cells,
mesenchymal cells and immune cells. Macrophages, also known as tumor-associated …
mesenchymal cells and immune cells. Macrophages, also known as tumor-associated …
[HTML][HTML] Human Monocytes Are Suitable Carriers for the Delivery of Oncolytic Herpes Simplex Virus Type 1 In Vitro and in a Chicken Embryo Chorioallantoic …
A Reale, L Krutzke, M Cadamuro, A Vitiello… - International Journal of …, 2023 - mdpi.com
Oncolytic viruses (OVs) are promising therapeutics for tumors with a poor prognosis. An OV
based on herpes simplex virus type 1 (oHSV-1), talimogene laherparepvec (T-VEC), has …
based on herpes simplex virus type 1 (oHSV-1), talimogene laherparepvec (T-VEC), has …
[HTML][HTML] Tumour microenvironment in pheochromocytoma and paraganglioma
S Martinelli, F Amore, L Canu, M Maggi… - Frontiers in …, 2023 - frontiersin.org
Pheochromocytomas and Paragangliomas (Pheo/PGL) are rare catecholamine-producing
tumours derived from adrenal medulla or from the extra-adrenal paraganglia respectively …
tumours derived from adrenal medulla or from the extra-adrenal paraganglia respectively …
Immune contexture of cholangiocarcinoma
Immune contexture of cholangiocarcinoma : Current Opinion in Gastroenterology Immune
contexture of cholangiocarcinoma : Current Opinion in Gastroenterology Log in or Register …
contexture of cholangiocarcinoma : Current Opinion in Gastroenterology Log in or Register …
The role of tumor epithelial-mesenchymal transition and macrophage crosstalk in cancer progression
Abstract Purpose of Review The purpose of this review is to summarize the recently
published findings regarding the role of epithelial to mesenchymal transition (EMT) in tumor …
published findings regarding the role of epithelial to mesenchymal transition (EMT) in tumor …
[HTML][HTML] TREM2 is associated with advanced stages and inferior prognosis in oral squamous cell carcinoma
AK Struckmeier, A Radermacher, M Fehrenz… - Cancers, 2022 - mdpi.com
Simple Summary Triggering receptor expressed on myeloid cells 2 (TREM2) is an appealing
candidate for immunotherapy. However, results regarding its role in multiple cancers are …
candidate for immunotherapy. However, results regarding its role in multiple cancers are …